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ABSTRACT 
BACKGROUND 
Post operative discomfort that arises from pain is annoying for both child and 
parents. This resulted in the excessive use of Opioids and NSAIDS post 
operatively which have significant side effects. So adding an adjuvant like 
Midazolam to caudal bupivacaine prolongs post operative pain relief and avoids 
these side effects. 
AIM 
To compare the efficacy and safety of using caudal epidural administration of 
preservative free Midazolam (50 Microgram per kg) with 0.25 % bupivacaine vs 
plain 0.25% bupivacaine for providing post op pain relief in children undergoing 
elective lower abdominal surgeries. 
MATERIALS AND METHODS 
It was a prospective randomized case control study done on 60 patients age 
between 2 – 8 years of American society of Anaesthesiologist (ASA) Grade 1 & 2 
posted for lower abdominal surgeries under standardized General Anaesthesia. 
After induction patients were allocated randomly into two groups.  
GROUP B received caudal block with inj. Bupivacaine (0.25%) 1 ml per kg & 
Group BM received caudal block with inj. Bupivacaine (0.25%) 1 ml per kg and 
50 micro gram per kg of preservative free midazolam. All children were 
continuously observed in recovery room for two hours after which they are shifted 
to recovery room. The FLACC pain score, Ramsay sedation score and vitals 
recorded at regular intervals for upto 24 hrs after surgery. 
RESULT 
Pain score were comparable in both the groups for 1st one hour post operatively. 
After that Group BM had low pain scores compared to Group B. The mean 
duration of post operative analgesia in group BM was 12.49 ± 1.19 hrs. and that of 
group b was 5.11 ± 0.50 hrs. it was statistically significant with a p value < 0.05. 
Sedation scores were higher in the Group BM for 1st one hour compared to group 
B with no adverse effects. There was no significant haemodynamic changes in both 
the groups. 
Conclusion 
I conclude the that administration of preservative free midazolam with bupivacaine 
for caudal epidural block increases the duration of post operative analgesia without 
producing any adverse effects compared with bupivacaine alone. Thus low dose 
preservative free midazolam can be used as an adjuvant to local anesthetics in 
caudal epidural block for prolonging analgesic effects. 
Key Words 
Bupivacaine, Midazolam, caudal analgesia, anesthesia.  
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INTRODUCTION 
The term ‘PAIN’ meaning penalty is derived from the term ‘poena’ 
Pain is defined as “unpleasant emotional or sensory experience with 
associated potential or actual tissue damage or described in terms of such 
damage”. 
It is a proven fact, that regardless of age, neonates, infants, children, even 
a preterm child all can perceive pain. They show a severe stress response 
to painful stimuli. 
PAIN PATHWAY: 
 The noxious stimulus at the time of injury induces a local 
inflammatory response in the periphery i.e. sensitization of 
nociceptors and primary hyperalgesia. 
 The noxious input is then conducted to CNS by ‘A’ delta and ‘C’ 
fibres. This initiates a sequence of events i.e. reflex withdrawal 
from stimulus, aversive behavior and pain perception. 
 The sustained noxious input from ‘C’ fibres produces central 
sensitization which alters sensory processing in spinal cord 
(neuroplasticity) leading to allodynia and hyperalgesia at the site of 
injury. 
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In the early life (Neonatal period) there are certain differences in the 
mechanism of pain response as follows: 
1. The threshold for pain sensation is lower than adults and they have 
exaggerated reflex responses. 
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2. In the motor component of withdrawal reflex, there is less coordination 
i.e. involvement of whole body movements during withdrawal response. 
3. The receptive fields of sensory neurons are larger and there is greater 
overlapping which influences sensory localization and discrimination 
4. Both ‘A’ delta and ‘C’ fibres matures after birth and that too ‘C’ fiber 
much later than ‘A’ delta; - so in early life ‘A’ delta involved in central 
sensitization rather than ‘C’ fibre. 
5. The peripheral inflammatory response is immature at birth. 
 
PAIN ASSESSMENT IN CHILDREN: 
The vast range of physiological and behavioral responses, 
cognitive abilities, psychological development from the period between 
the preterm neonate and adolescent poses enormous problems for valid 
and reliable measurement. 
1. Self report measures:  
 VAS - Visual Analog Scale  
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 FACES  
 
 
 Manchester pain scale 
 5 
 
2. Observational behavioral measures:  
 FLACC  -  Faces, Legs, Activity, Cry & Consolability  
 CHEOPS - Children's Hospital of Eastern Ontario Pain 
Scale 
 CRIES - Crying Requires increased oxygen administration  
      Increased vital signs Expression Sleeplessness 
 COMFORT 
 Objective Pain score  
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FLACC behavioral pain score: total score 0_10 
 
Criteria Score 0 Score 1 Score 2 
Face 
No particular 
expression or 
smile 
Occasional 
grimace or frown, 
withdrawn, 
uninterested 
Frequent to 
constant 
 quivering chin, 
clenched jaw 
Legs Normal position or relaxed 
Uneasy, restless, 
tense 
Kicking or legs 
drawn up 
Cry 
No cry  
(awake or 
asleep) 
Moans or 
whimpers; 
occasional 
complaint 
Crying steadily, 
screams or sobs, 
frequent 
complaints 
Activity 
Lying quietly, 
normal position, 
moves easily 
Squirming, 
shifting back and 
forth tense 
Arched, rigid or 
jerking 
Consolability Content relaxed 
Reassured by 
occasional 
touching, hugging 
or being talked to 
distractible 
Difficult to console 
or  comfort 
 
 
  
 7 
 
Drugs acting at various sites of pain pathway: 
 Peripheral level-Local anesthetics,  NSAIDS, opioids 
 Spinal cord- opioids, alpha 2 agonists, local anesthetics 
 Cortical level- opioids 
Various combined modes of treatment are used for effective 
treatment of pain. Among these methods the pain relief provided 
by regional anesthesia is more efficient and it has several 
advantages they are: 
I. Analgesia provided by block reduces general anesthetic 
requirements,    resulting in: 
 More rapid recovery 
 Reduced incidence of PONV 
 Decreased  postoperative opioid  requirement 
 Early return of appetite 
 Earlier discharge 
II.  Regional block avoids undesirable autonomic reflexes like  
 Laryngospasm  
 Cardiac dysrhythmias  
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III. Regional block provides adequate muscle relaxation  
 Use of muscle relaxant avoided, decreased risk of respiratory 
insufficiency 
IV.  After delicate surgery immobilization of child is easier because of 
some residual motor blockade and adequate pain relief 
V. Intra and post operative bleeding reduced 
VI. Diminished stress response 
VII. Greater cardiovascular stability 
VIII. Fewer episodes of hypoxia 
IX. Reduced need for postoperative  ventilatory  support 
X.  Children are free of hypotensive response from sympathectomy 
produced by LA 
XI. Regional anaesthesia is the technique of choice in children with 
the: 
 History of malignant hyperthermia 
 Bronchopulmonary dysplasia 
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Anatomic & Physiologic factors influencing regional block 
in children 
Factors Anaesthetic implications 
Lower termination of spinal cord 
(L3-4) 
Epidural approaches above L3 to be  
avoided whenever possible 
Lower projection of Dural sac 
(S3-4)  
Increased risk of inadvertent 
penetration  
of the Dura mater 
Delayed myelinization of nerve 
fibres 
Intramural penetration of local  
anesthetics is easier  
Onset time shortened  
Diluted local anesthetic is effective 
as  
more concentrated anesthetic  
Cartilaginous structure of bones  
and vertebrae  
Danger of direct trauma  
Use short and short beveled needles  
Changing axis of coccyx and  
absence of growth of sacral hiatus  
Identification of sacral hiatus 
difficult above 6-8 years  
Increased failure rate of caudal 
anesthesia  
Delayed ossification and growth 
of iliac crests  
Tuffier’s line passes over L5-S1 
interspaces  
Increased fluidity of epidural fat Increased diffusion of local anesthetic up to 6-7 years of age with 
excellent caudal blockade 
Loose attachment of sheaths and 
aponeurosis to underlying 
structures 
Larger volume of LA for epidural 
blocks due  
to leakage along spinal nerve roots 
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Sympathetic immaturity, 
diminished autonomic adaptability 
of the heart, smaller vascular bed 
in lower extremities 
Hemodynamic stability during 
neuraxial blocks 
Fluid preloading and use of 
vasoactive agents not needed. 
Low plasma protein content (HSA 
and AAG) 
Increased unbound free fraction of 
all local anesthetic: greater danger of 
systemic toxicity 
Increased cardiac output and heart 
rate 
Increased regional blood flow 
resulting in increased systemic 
absorption of LA: shorter duration of 
action 
Enzymatic immaturity Slower metabolism of LA with risk 
of accumulation 
Increased extracellular fluids Increased distribution volume of LA with increased risk of accumulation 
after continuous infusion 
Absorption from epidural space The time (Tmax) to reach peak plasma concentration (Cmax) 
remains basically unchanged 
Metabolism 
Low plasma cholinesterase activity 
Decreased cytochrome P450 activity 
Phase 2 reactions immature up to 
3yrs of age 
Elimination half life 
>1yr: same as adults 
< 1yr: increased thus favoring 
accumulation with repeated 
injections 
Systemic toxicity Thresholds of toxicity of the unbound form of LA: 
0.3 μg/ml for bupivacaine 
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AIM OF STUDY 
This study compares the efficacy and safety of using caudal 
epidural administration of Midazolam 50microgram/kg with 0.25% 
Bupivacaine Vs 0.25% Bupivacaine, for providing postoperative pain 
relief in children undergoing elective lower abdominal surgeries. 
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CAUDAL ANAESTHESIA 
It is the oldest and still most commonly used form of regional 
technique in children 
HISTORY: 
 Cathelin and Sicard-first described this technique in 1907 
 Steckel of Germany-first used this technique in 1909 
 Meeher and Bonar-first used this technique in obstetrics and 
Gynecology in 1923 
 Edwards &Hingson-developed continuous caudal technique in 
1942 
ANATOMY OF CAUDAL BLOCK: 
Caudal block is performed via sacral hiatus through sacrococcygeal 
membrane. 
The posterior superior iliac spines and sacral hiatus form an 
equilateral triangle. 
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SACRAL HIATUS: 
 Sacral hiatus is a bony defect, triangular in shape and situated at 
the lower end of sacrum just above sacrococcygeal junction. It 
results from the non fusion of the 5th sacral and sometimes 4th 
sacral vertebral arches. 
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 It appears as an inverted U or V shaped opening limited laterally by 
two palpable bony structures, the sacral cornu and covered by 
sacrococcygeal membrane (continuation of ligamentum flavum 
sacrally) which lies beneath skin and subcutaneous tissue. The 
shape and size of hiatus changes with increasing age. 
 
 
 In neonate long axis of sacrum and coccyx form an acute angle. As 
age increases angle increases and thus close the sacral hiatus and 
makes caudal anesthesia more difficult to perform after 17yrs of 
age. 
 The caudal epidural space in a neonate is filled with epidural fat, 
which has a gelatinous, spongy appearance with distinct spaces 
between the fat globules and very few connective tissue fibers, so 
uniform and rapid spread of local anesthetic solutions occur.  
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 After 6 to 7 years of age, the epidural fat gets denser and 
surrounded by fibrous strands thereby spread of local anesthetics is 
limited. 
 Caudal epidural space is highly vascularized like lumbar epidural 
space and the veins here are without valves and thus inadvertent 
intravascular injection  leads to systemic toxicity. 
 The characteristic of caudal epidural space is that it communicates 
freely with perineural space. This facilitates improved quality of 
block even with dilute local anaesthetic solutions in large volumes. 
 Age and weight of patient influence the distance between epidural 
space and skin. 
 The mean distance from skin to sacral epidural space in children 
aged >2months &< 7 years is 21mm. 
 The distance from apex of sacral hiatus to Dural sac in children > 
10 month &<18 years is 30+/10.4mm. So a short(i.e.25mm length) 
and short beveled needle is adequate to reach the sacral epidural 
space and prevent inadvertent Dural puncture 
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INDICATION: 
1) Surgeries below the diaphragm especially in sacral &lumbar 
areas  e.g. orthopedic procedures on lower limb and pelvic 
girdle. 
2) Lower abdominal surgeries e.g., urinary and lower digestive 
tract surgeries and  
3) As sole anesthetic technique in fully awake ex-premature 
infants younger than 60 weeks of post conceptual age. 
CONTRAINDICATION: 
 Infection at the local site 
 Bleeding diathesis 
 Sacral malformation 
 Raised intracranial pressure 
 Meningitis 
TECHNIQUE: 
All equipments including block tray, resuscitation equipment and suction 
are kept ready. 
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POSITIONING: 
1) The child is placed in lateral Sims position, left side down for 
right handed person with the lower leg slightly flexed at the hip and upper 
leg more flexed such that it lies over and above the lower leg and in 
contact with bed. This maneuver separates the buttocks. This is the 
preferred position. 
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Other positions: 
2) Prone position with pillow under the pelvis. Both legs are 
rotated so that the toes of both feet are facing medially, this again 
separates the buttocks 
 
The sacral hiatus is identified by means of shallow (U or V) 
depression and 22 G short beveled needle is inserted at an angle of 60 
degree  at the apex of hiatus until a distinct pop is felt. The pop is felt as 
the needle penetrates sacrococcygeal ligament. 
 
 
The needle is inserted at the apex of hiatus because it is the deepest 
part of sacral canal and so that the entire bevel of the needle is within the 
canal 
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A longer bevel may be partly outside the canal or may traumatize a 
vessel or periosteum as it is advanced. 
The needle both hub and shank, is then depressed toward the skin 
so that the needle aligns approx. in the long axis of canal and then 
inserted further. 
The needle is stabilized and after negative aspiration for blood and 
CSF, the drug is administered in small volumes with repeated aspiration. 
At the time of drug administration ECG is carefully observed (for 
doubling in size of T wave or tachycardia) as a sign of intravascular 
injection. 
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SIGNS OF CORRECT NEEDLE PLACEMENT: 
 No CSF, air ,blood on aspiration 
 No subcutaneous bulge or superficial crepitus after injection of 2-
3ml of local anesthetic 
 No tissue resistance to injection 
 Needle should be able to move in the canal 
 No local pain during injection 
 Whoosh test-Inject 2 to 4ml of air and listen with ear or 
stethoscope over lumbar region. Not done nowadays  
 If catheter is inserted, it should enter the canal freely 
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SELECTION OF DRUG: 
The drug dosage for caudal epidural blockade depends on two 
factors: 
1) Volume of local anesthetics (not the concentration) 
2) Volume of epidural space which varies with age. 
Dosage calculation is based on these two formulae mainly: 
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ARMITAGE’s FORMULA: 
 0.5ml per kg-all sacral dermatomes are blocked 
 1ml per kg-sacral and lumbar dermatomes are blocked 
 1.25ml per kg-sacral, lumbar and lower thoracic dermatomes are 
blocked 
TAKASAKI’S FORMULA: 
Volume (ml)=0.05ml per kg/dermatome to be blocked 
Among these two, dosage of Armitage remains most dependable. 
Takasaki gives best approximated clinical result. 
The level of block depends on volume of drug given whereas density of 
blockade depends on the concentration of drug 
COMPLICATIONS: 
o Accidental intravascular or intraosseous  injection 
o Dural puncture 
o Vascular injury leading to epidural hematoma 
o Neural injury 
o Infection-meningitis  and epidural abscess 
o Urinary retention 
o Complete or partial failure of blocks 
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 Infection - It is of grave concern especially when it occurs 
either subarachnoid or the epidural space. 
 Meningitis and epidural abscess are the most serious 
complication. The signs and symptoms are same for both 
except for fever, raised ESR and leucocytes count in epidural 
abscess. So whenever a child develops pyrexia of unknown 
origin with indwelling catheter, it is mandatory to remove 
the catheter immediately. 
 Epidural hematoma – a very rare complication. Rapid 
diagnosis, immediate intervention and decompression give 
better outcomes. 
 Urinary retention very rare can occur with use of opioids. 
 Block failure rate is 3 to 5% and failure rate increases 
especially in children >7 years of age. 
 
CONTINOUS CAUDAL CATHETER TECHNIQUE: 
The indications are similar to single shot technique, but it is used 
when prolonged analgesia required. 
Procedure: 
Similar to single shot but the needle used is larger, either a 
Crawford needle or large i.v. cannula(21G epidural catheter pass through 
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18G i.v. cannula).The advantage of Crawford needle compared to Tuohy 
needle are, Crawford needle’s bevel lies in alignment with shaft of needle 
so that the catheter exits the needle in a straight line rather at an angle as 
with Tuohy. The catheter is advanced 2 to 3cm or more depending on 
level of block required. The catheter tip is placed at or near the midpoint 
of dermatomes involved in surgical incision. 
Continuous thoracic epidural analgesia can be provided by threading the 
catheter from caudal space especially in children less than 6 years of age. 
Such catheters can get kinked or lodged in the dural sleeve. 
Correct placement confirmed by: 
 Ease of injection 
 Negative aspiration 
 Radiographic or USG  imaging 
 Nerve stimulation through catheter 
 ECG recording 
 The main disadvantage of this technique is infection so a double 
occlusive dressing is applied. 
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PHARMACOLOGY OF BUPIVACAINE 
Bupivacaine is an amide local anesthetic agent. It was first 
synthesized by Ekenstam in 1957 and was first used clinically by widmon 
and Telimo in 1963.It belongs to n-alkyl substituted pipecholylxylidines. 
It is produced as racemic mixture containing both S and R in equal 
proportion. It is supplied as a hydrochloride salt. 
CHEMICAL STRUCTURE: 
 
 
 Bupivacaine has a butyl group on the piperidine nitrogen atom of 
the molecule. 
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 It is a long acting local anesthetic drug with high anesthetic 
potency. 
 It is more lipid soluble, highly protein bound and greater intrinsic 
potency 
 It crosses the placenta and blood brain barrier. 
 
PHYSIO-CHEMICAL PROFILE: 
 Molecular weight-288 
 pka-8.1 
 Plasma protein binding-95% 
 Partition  coefficient -28( lipid solubility) 
 Clearance-8.3l/min 
 Elimination t1/2-210min 
 Elimination t1/2 in neonates & young infants-480-720min 
 Umbilical vein-maternal arterial concentration ratio – 0.32 
PHARMACOLOGICAL PROPERTIES: 
 Onset              -   Moderate 
 Potency          -   4 
 Duration         -  Long 
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MECHANISM OF ACTION: 
Like all local anesthetics it inhibits Na channels. It decreases or 
prevents large transient increase in permeability of the cell membranes to 
Na ions that causes depolarization of the membrane and thereby blocks 
nerve conduction. The permeability of resting nerve membrane to 
potassium ions as well as sodium ions are reduced and hence got a 
stabilizing action on all excitable membranes. 
PHARMACOKINETICS: 
 Rapidly absorbed from the site of injection 
 Peak systemic concentration reached 5-30 min after administration 
 Duration of action-360 to 720 minutes 
 Dose dependent first pass pulmonary extraction occurs 
 Metabolism in liver- dealkylation to pipecoloxylidine,aromatic 
hydroxylation 
 Excretion –only 5% as unchanged drug and rest as metabolites 
PREPARATION: 
 0.25%,0.5% solutions in 10,20ml vials respectively 
 0.5%(5mg/ml) bupivacaine with 80mg dextrose(to increase 
baricity)in 4ml ampoules for subarachnoid injection(baricity-
1.0207) 
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MAXIMAL DOSE: 
 2.5mg/kg body weight and strength used is 0.25-0.75% with or 
without adrenaline. Adrenaline causes mild intensification and 
modest prolongation of blockade, but reduces its toxicity. 
EFFECTS: 
 Local –nerve blockade 
 Regional-pain, temperature, touch, motor power and vasomotor 
tone are blocked 
 Systemic effects – due to systemic absorption or accidental i.v. 
administration 
 It is highly potent (4 times) more than lignocaine. Its duration of 
action longer. 
 It produces differential sensory/motor blockade 
ADVERSE EFFECTS: 
 Central Nervous System : Toxicity produces 
 Circumoral numbness, metallic taste 
 Light headedness, dizziness, tinnitus 
 Confusion, slurred speech 
 Convulsions 
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 Cardio Vascular System : Effect is dose related 
 Depresses automaticity and contractility of heart 
 It decreases rapid phase of depolarization (vmax) in purkinje 
fibres & ventricular muscle causes prolonged PR and QT 
interval 
 Re-entrant phenomenon and ventricular arrthymias  can occur 
 Slow rate of recovery from use dependent blockade (Na 
channels are blocked in fast in slow out manner) 
 Results mostly from high lipid solubility 
 R-enantiomer is more toxic than S-enantiomer 
 Pregnancy increases cardiotoxic effects of bupivacaine 
ALLERIC REACTION:  
Due to preservative methyl paraben 
USES: 
 Central neuroaxial blocks 
 Peripheral nerve blockade  
 For local infiltration subcutaneously 
CONTRAINDICATION: 
 Known hypersensitivity  to amide local anesthetics 
 Intravenous regional anesthesia  
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PHARMACOLOGY OF MIDAZOLAM 
It was the first water soluble benzodiazepine used clinically, 
Synthesized by Fryer &Walser’s in 1976. It is the only benzodiazepine 
approved by FDA for use in neonates. 
PHYSIOCHEMICAL PROPERTIES: 
CHEMICAL STRUTURE: 
 
 
 Imidazole ring - responsible for stability in solution and rapid 
metabolism  
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 PH dependent solubility – water soluble at acidic pH and it 
becomes lipid soluble at physiological pH by means of inter 
molecular re-arrangement 
 Highly lipophilic  
 Molecular weight – 362 
 pKa – 6.2 
 Plasma protein binding - 90 – 98% 
 Clearance - 6-11ml per kg per minute 
 Elimination t1/2 – 2 hours in adults , 6 – 12 hours in Neonates 
 Midazolam solution contains  0.01% di-sodium edentate, 0.8% 
Nacl &1% benzyl alcohol as a preservative  
 Preservative free form also available which is used for intrathecal, 
epidural and caudal epidural administration  
PHARMACOLOGICAL PROPERTIES: 
 Onset         -        rapid (30 – 60 seconds after giving i.v. (peak 
effect 3 – 5 minutes)  
 Potency     -        high 
 Duration    -       shorter 
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MECHANISM OF ACTION: 
 Benzodiazepines act on GABA A receptor. GABA is the principal 
inhibitory neurotransmitter in CNS. 
 Benzodiazepines bind to BZD – GABA receptor, increases the 
frequency of channel opening (GABA facilitatory) leading to hyper 
polarization of postsynaptic neuron. 
 Caudal epidural, epidural or intrathecal Midazolam – produces 
analgesia via acting on GABA A receptor complex in the spinal 
cord, especially in the lamina II of dorsal horn of spinal cord 
(substantia gelatinosa). 
 Intrathecal Midazolam – reduces excitatory GABA mediated neuro 
transmission in inter neurons leading to decrease in excitability of 
spinal dorsal horn neuron. 
 
PHARMACO KINETICS: 
 Absorption - Highly lipid soluble so well absorbed.  Drug can 
be given oral, i.v, i.m, rectal, nasal and sublingual. After oral 
administration 50% undergoes first pass effect. 
 Distribution – Drug is lipid soluble and it penetrates blood brain 
barrier.  
 
 33 
 
 Redistribution is rapid resulting in shorter duration of action 
 Initial distribution half-life is 3-10 minutes.  
 Its plasma protein binding capacity is 90 – 98%.  
 Bio- transformation – Metabolism occurs in liver which 
undergoes oxidation reaction (aliphatic hydroxylation or N- 
dealkylation) resulting in 1- hydroxy metabolite.  
 Drug undergoes oxidation faster thereby resulting in greater 
hepatic clearance and shorter elimination half life.  
 Age and smoking has no impact on its metabolism. Chronic 
alcoholism increases clearance of Midazolam.  
 1- Hydroxyl metabolite has clinical potency equivalent to 20 – 
30 % of Midazolam, has mild CNS depressant activity 
conjugated and excreted in urine. 
 Excretion – profound sedation occurs in patients with renal 
impairment due to accumulation of 1- hydroxyl metabolite. In 
elderly patient half- life prolonged.  
 In obese patients also half-life prolonged but clearance is not 
altered due to delayed return of the drug to plasma from adipose 
tissue. 
 Elimination half life shorter 
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PHARMACO DYNAMIC EFFECTS 
 Central Nervous system: 
 Hypnotic, sedative, anxiolytic, anterograde amnesia, anticonvulsant 
and centrally produced muscle relaxant properties. 
 Sedation, anterograde amnesia and anticonvulsant properties via 
alpha 1 receptor. 
 Anxiolysis and muscle relaxation via acting on alpha 2 GABA A 
receptor. 
 It causes decreases in cerebral metabolic rate and cerebral blood 
flow. The ceiling effect occurs on decrease in CMRO2 so an 
isoelectric EEG does not occur. 
 It increases seizure threshold to local anaesthics. Cerebral 
vasomotor response to CO2 is preserved. 
 It does not prevent ICT increase during laryngoscopy and 
intubation. 
 It reduces MAC by 30%. 
 Paradoxical excitement in 1% of patients. 
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 Respiratory system: 
 Causes dose related respiratory depression.  It decreases minute 
ventilation.  
 Ventilatory response curves to CO2 are flatter than normal.  
 Peak onset of respiratory depression occurs in 3 minutes and lasts 
for 1- 2 hours. As faster the drug given faster the respiratory 
depression and apnoea.  
 BZD & opioid have synergistic effect on respiratory depression. It 
depresses swallowing reflexes and causes decrease in upper airway 
activity. 
 
 Cardio vascular system: 
 Peak effect occurs in the first 10 minutes of administration. It 
causes mild decrease in blood pressure due to decrease in systemic 
vascular resistance. 
 Heart rate, cardiac output and ventricular filling pressure are 
maintained. Midazolam is safe and effective for induction in 
patients with severe aortic stenosis despite the hypotension. 
 Does not prevent stress response to laryngoscopy and surgery. 
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PREPARATIONS: 
 Available as acidified aqueous form 
 Midazolam vial (1 mg per ml) 
 Midazolam Syrup (2 mg per ml) 
 Preservative free midazolam (5 mg per ml) 
Uses: 
1. I.V. Sedation –  Preop premedication; Periop during regional or 
local anesthesia and postoperatively 
2. Premedication in children 
 Oral                – >   0.25 – 1mg per kg (max. 20 mg) 
given 30 to    40 minutes before surgery. It makes 
child calm and sedated so child can be easily 
separated from parents and brought to the theatre. 
 I.m.                  – >   0.12 – 0.15 mg per kg (max. 2.5 
mg) 
 Rectal             – >   0.75 – 1mg per kg  
 Nasal              – >   0.2 mg per kg .cause nasal 
irritation and discomfort. 
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3. Induction and maintenance of anesthesia  
Induction dose    - > 0.05 – 0.15 mg per kg  
Co- induction dose  - > 0.1 mg per kg 
Maintenance  - > 0.05 mg per kg prn 
         1 micro gm per kg per min 
  
4. Anticonvulsant – Seizures caused by LA, alcohol withdrawal
   
5. Nausea and vomiting prophylaxis 
6. Sedation in ICU. 
ADVERSE EFFECTS: 
 Respiratory depression 
 Hypotension 
 Prolonged sedation 
 Paradoxical excitement very rare 
  
 38 
 
FLUMAZENIL 
It is a competitive benzodiazepine antagonist, reverses agonist 
effects of benzodiazepines in a dose dependent manner. 
Chemical structure: 
1, 4 imidazo, benzodiazine derivative, phenyl group replaced by 
carbonyl group. 
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Pharmacokinetics: 
 It is metabolized in liver to metabolites  
 Short acting drug due to most rapid clearance and shortest 
elimination half life (1 hour). 
 DOSE: 0.2mg repeated up to 3mg 
 Onset of action – rapid 
 Peak effect-1 to 3 minutes 
 Duration of action- 30 to 60 min 
Uses: 
It reverses sedation, respiratory depression and amnesia of 
benzodiazepines. 
Side effect: 
Resedation can occur because of shortest half life 
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REVIEW OF LITERATURE 
 Naguib et al,1995 
They compared the analgesic efficacy of caudal  midazolam, 
caudal bupivacaine and caudal bupivacaine and midazolam mixture for 
post operative analgesia in children undergoing inguinal herniotomy. 
They selected 45 pediatric patients and divided into three groups(15 
patients in each) .Group 1 received 1ml per kg of 0.25% bupivacaine, 
Group 2 received midazolam 50mcg per kg with normal saline 1ml per 
kg,Group 3 received 1ml per kg of 0.25% bupivacaine and midazolam 
50mcg per kg. No premedication was given; all children were induced 
with inhalation of nitrous oxide, oxygen and halothane, maintained on 
spontaneous respiration using 70% nitrous oxide and oxygen via Ayre’s T 
piece. Intra operatively opioids or no other sedatives used. The child is 
monitored intraop and post operatively for vitals like heart rate, blood 
pressure, respiratory rate and oxygen saturation for first 24 hours. Pain is 
assessed by means of observer pain scale which is a six point scale and 
postoperative behavior was assessed by means of three point scale. The 
duration of analgesia (recovery to first analgesic time) and total number 
of analgesic doses in the first 24hrs are compared. The children with a 
pain score >_ 3, received paracetamol suppository in a dose related body 
weight basis. There was a statistically significant difference (p<0.001) 
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between the bupivacaine midazolam group than the other two groups i.e. 
recovery to first analgesic time was longer in the bupivacaine midazolam 
group. Group 1 and 2 patients (p<0.05) received more doses of 
paracetamol than group 3 for maintenance of analgesia. They also 
observed that caudal midazolam (group 2 and 3) doesn’t cause change in 
postoperative behavior compared to bupivacaine group in fact group 2 & 
3 patients are calm and cheerful immediately after recovery from 
anesthesia compared to group 1.vomiting occurred postoperatively in two 
and one patients in group 1  & 3 respectively. In this study there is no 
instance of side effects like hypotension, bradycardia, respiratory 
depression prolonged sedation or residual paralysis. 
 
 Gulec et al,1998 
They did a study on 60 children undergoing inguinal or 
genitourinary surgery divided into three groups comparing caudal 
bupivacaine midazolam, bupivacaine morphine and plain bupivacaine 
(each 20 patients).After induction of general anesthesia  one  group  
received 0.75ml per kg of 0.125% bupivacaine and midazolam 50mcg per 
kg, another group received 0.75ml per kg of 0.125% and   morphine 
1%0.05mg per kg and  other group  received 0.75ml per kg of 0.125% 
bupivacaine  alone. The heart rate, blood pressure, SP02, pain score n 
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sedation score and any adverse effects are noted. They concluded that 
duration of analgesia was prolonged in the bupivacaine -midazolam 
group(1269 ±72 min)  compared  to bupivacaine-morphine group 
(870±78min) and  bupivacaine group(8.15±1.3 hr).There is significant 
difference  between the bupivacaine-midazolam group and bupivacaine(P 
<0.001),between bupivacaine midazolam and bupivacaine morphine(p 
<0.01).Sedation scores higher in the bupivacaine midazolam and 
morphine compared to bupivacaine alone (p <0.01)  They concluded that 
caudal administration of a bupivacaine-midazolam mixture produces 
prolonged  post-operative analgesia than  bupivacaine-morphine mixture 
and bupivacaine  alone without  producing any adverse effects. 
 
 Tomoko Nishiyama et al, 1998 
They did a randomized controlled study comparing the effects of 
epidural midazolam for postoperative analgesia in patients undergoing 
upper abdominal surgery. They concluded that epidural infusion of 
midazolam  and bupivacaine provides better analgesia, amnesia and 
sedation compared to bupivacaine alone without causing any adverse 
effects. 
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 Batra et al, 1999 
They did a randomized controlled study to evaluate the effect of 
adding midazolam intrathecally to bupivacaine for postoperative 
analgesia in patients undergoing knee arthroscopy.30 patients selected 
and divided into two groups, group B (bupivacaine), group M 
(bupivacaine and midazolam).The blood pressure, heart rate, oxygen 
saturation, pain using VAS score, sedation score, motor block, high-level 
of sensory block and block regression all recorded. Higher VAS score 
was observed in group M compared to group B with a significant p value 
< 0.05.Time to rescue analgesia, regression of sensory block all are 
prolonged in group M compared to B, but there was no difference in 
motor block. They concluded that addition of intrathecal midazolam to 
bupivacaine prolonged post operative analgesia without any adverse 
effect. 
 
 Mahajan et al,2001  
They did a comparative study to evaluate the postoperative pain 
relief in children, undergoing genitourinary surgery using caudal 
bupivacaine and bupivacaine midazolam mixture. They selected 30 
patients divided into two groups(each group 15 patients) after induction 
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of GA, group B` received 0.5ml per kg of 0.25% bupivacaine & group 
BM received 0.5mi/kg of 0.25% bupivacaine with 50mcg per kg of 
midazolam.,duration of analgesia and analgesic requirement are 
compared. In the intraop and postop period heart rate, blood pressure, 
oxygen saturation is monitored. Pain was assessed postoperatively by 
means of objective pain score at regular intervals for 12 hours. If pain 
score more than 4 analgesia was given.The results of the study show that 
there is a statistically significant difference between two groups.(i.e.p 
<0.05) . The duration of analgesia for group BM(11+/0.5h) longer than 
group B(7.4+/2.1h) ,60%  and 26.6%of children in group B & group BM 
received analgesic supplements within 6 hrs after surgery(p0.05). In the 
two groups there was no significant  
 Mark Ansermino,2003 
They did a study comparing the effects of adding nonopioid 
additives to LA for caudal blockade in children. They found duration of 
analgesia was prolonged with midazolam, ketamine and clonidine. 
 Yaksh et al,2004 
They did a study on the use of intrathecal midazolam in humans. 
They concluded that midazolam has analgesic property without 
prominent autonomic and motor side effects. 
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 Bano et al,2004 
They did a randomized controlled study comparing caudal 
bupivacaine and bupivacaine midazolam for postoperative analgesia in 
children. Sixty children were selected and randomly allocated into two 
groups. After induction of GA, Group A received 0.75ml/kg of 0.25% 
bupivacaine and Group B received 0.75ml/kg of 0.25% bupivacaine and 
50mcg/kg of 0.1% midazolam.The heart rate, blood pressure, respiratory 
rate, pain score and sedation score was recorded. The pain score was >4 
diclofenac suppository given. They concluded that there was no 
significant difference in heart rate, blood pressure, respiratory rate 
between two groups. The duration of analgesia was prolonged in the 
group B (bupivacaine midazolam)i.e.21.41+/2.7 hrs compared to group A 
(bupivacaine)i.e.9.97+/2.25 hrs and it is statistically significant 
(p<0.001).The sedation score was higher in the bupivacaine midazolam in 
the first one hour postoperatively with a significant difference i.e. p value 
<0.003.There was no significant adverse effects during this study.  
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 Kumar et al,2005 
They did a randomized study comparing the effects of adding 
midazolam (50mcg per kg), ketamine (0.5mg per kg) and neostigmine to 
caudal bupivacaine for introp and postop analgesia in children 
undergoing inguinal herniotomy.They selected 80 patients divided into 4 
groups: 
No premedication was given. After induction of general anesthesia 
group B received 1ml/kg of 0.25% bupivacaine, group BM received 
1ml/kg of 0.25% Bupivacaine and preservative free midazolam 
(50mcg/kg), group BK bupivacaine and preservative free ketamine 
(0.5mg/kg) & group BN bupivacaine and neostigmine (2mcg/kg). The 
heart rate, blood pressure, SPO2 and pain score, sedation score & motor 
block was assessed up to 24hrs after surgery. There was a statistically 
considerable difference (p<0.05)in the duration of analgesia, in group 
BN(19.6+/4.2hr),group BM(16.8+/3.9hr),group BK(11.6+/4.4hr) & group 
B(7.6+/5.2hr).Though the duration of pain relief greater in BN compared 
to BM it was not statistically significant(p.0.05).There was no statistically 
significant difference among sedation scores. Vomiting occurred in 
3patients in groupBN, 2 in group BK and B each & one patient in group 
BM, there was no other side effects like bradycardia, hypotension, 
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pruritus and motor weakness. Follow up to 2 months after surgery 
revealed no adverse neurological sequelae.   
 Shahriari Ali et al,2007 
They did a randomized double blind study comparing the effects of 
caudal midazolam and caudal lignocaine with epinephrine & fentanyl 
mixture for postoperative analgesia in children undergoing hypospadias 
repair. They concluded that caudal midazolam provides equivalent 
analgesia to lignocaine adrenaline and fentanyl mixture. 
 Hong et al,2008 
They did a randomized double blind study to determine whether 
caudal midazolam combined with ropivacaine  affects  postoperative 
analgesia  ,sevoflurane requirement and recovery in pediatric day care 
hernioplasty. They selected 60 boys and divided into two groups. Group 
R received 1ml/kg of 2% ropivacaine and epinephrine (1:200000) and 
Group RM received 1ml/kg of 2% ropivacaine epinenephrine and 
midazolam 50mcg/kg under sevoflurane anesthesia. End tidal sevoflurane 
concentration after induction, before and after surgical stimulus, recovery 
pattern, post op sedation and post op pain score all noted. They concluded 
that caudal midazolam prolongs postoperative analgesia without affecting 
sevoflurane requirement and recovery. 
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 Pradhan B et al,2008 
They did a study comparing caudal bupivacaine and midazolam for 
post op analgesia in children undergoing herniotomy and pv sac ligation 
for hydrocele. Group 1 received 1ml per kg of 0.25% bupivacaine and 
Group 2 received midazolam 50mcg per kg with 1ml/kg of normal saline. 
The heart rate, blood  pressure, pain score, recovery to first analgesia, 
total analgesic requirement in 24hrs and any side effects are noted 
postoperatively. The recovery to first analgesia longer in group 1(>9hrs) 
compared to group 2(>7.30hrs) but not statistically significant. There was 
also no significant difference in analgesic quality, postop behavior. No 
adverse effects occurred except for vomiting in both groups. 
 Abosedira et al ,2009 
In this study they added midazolam to caudal ropivacaine in adults 
undergoing hemorrhoidectomy. They observed duration of analgesia was 
prolonged and reduced 24hr analgesic consumption without causing any 
adverse effects. 
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 Himabindu et al,2012 
They did a study on 50 patients undergoing infraumblical surgeries 
allocated into two groups. No analgesic premedication were given during 
this study. After preoxygenation child was induced with thiopentone and 
incubated using succinylcholine, child was maintained on spontaneous 
respiration using nitrous oxide ,oxygen and halothane 0.5% to 2% using 
Jackson Rees modification of Ayre‘s T-piece. Then child was turned to 
left lateral position, Group 1 received 1ml per kg of 0.25% bupivacaine 
and Group 2 received 1ml per kg of 0.25% bupivacaine and 50mcg per kg 
of midazolam into caudal epidural space. Intraoperatively heart rate, 
blood pressure and spo2 were noted. Pain score and other side effects like 
motor weakness, retention of urine, vomiting and respiratory depression 
also noted postoperatively for 24hrs.There is no significant hemodynamic 
changes in both groups. The duration of analgesia was prolonged in the 
bupivacaine midazolam group i.e. 72% of children were pain free up to 
6hrs after surgery whereas only 4%  in bupivacaine group (group 1). 
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 Idris ali et al,2014 
They did a study comparing the effects of adding midazolam to 
bupivacaine for post op analgesia in children.It was a randomized 
controlled study.They selected sixty patients divided into two groups. 
After induction of general anesthesia in group A caudal block 
given with 0.8ml/kg of 0.125% bupivacaine & 0.08mg/kg of midazolam 
and group B received 0.8ml/kg of 0.125% bupivacaine. The heart rate, 
blood pressure and time of first analgesic requirement are noted. The 
duration of analgesia in group A is 210+/30 min and group B is 
150+/30min.No adverse effects were reported. 
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 Kim et al, 
They did a double blind study to evaluate the postoperative 
analgesic effects of intrathecal midazolam with bupivacaine following 
haemorrhoidectomy. They selected 45 patients divided into three groups, 
1ml of 0.5% hyperbaric bupivacaine plus 0.2 ml of normal saline in 
control group, 1ml of bupivacaine with 0.2ml of 0.5% midazolam in BM1 
and 1ml of 0.5% bupivacaine with 0.4ml of 0.5% midazolam. The heart 
rate, blood pressure, SPO2 and VAS pain score noted. The duration of 
analgesia was prolonged in the midazolam group >2 hours and >4.5 hours 
in BM1 and BM2 respectively compared to control group. The time to 
first rescue analgesia noted. It was significantly greater with a p value of 
<0.01in the midazolam group compared to control. In the midazolam 
group it was significantly greater in the BM2 compared to BM1 with a p 
< 0.05).No adverse effects occurred during this study except for urinary 
retention in one patient in each group. Neurological examination revealed 
no deficit at the time of discharge  
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 Babita Ghai, 
This study was done to evaluate the effect of adding midazolam to 
continuous bupivacaine infusion for postoperative analgesia in children 
undergoing upper abdominal surgery. It was a prospective randomized 
control study done in 44 children of age group between 2 to 10 years 
divided into two groups. Group B received epidural infusion of 0.125% 
bupivacaine alone. Group BM received epidural bupivacaine and 
midazolam infusion 20 mcg per kg per hr for 12 hours at the rate of 0.2ml 
per kg per hr.Vitals, pain score, sedation score and motor block assessed 
for 24 hours. The rescue analgesia was given with i.v.fentanyl for first 12 
hours and tramadol for next 12 hours. The number of patients requiring 
and time to first rescue analgesia was prolonged in the group BM with a p 
value of < 0.001.The sedation scores are higher in the group BM 
postoperatively with a p value < 0.05.No motor block and adverse effects 
occurred during the study. There was no neurological deficit in the one 
year follow up. They concluded that epidural bupivacaine and midazolam 
reduces rescue analgesic requirement in children undergoing upper 
abdominal and flank surgery. 
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 Nil Raj Sharma et al 
They compared the epidural analgesia provided by bupivacaine 
combined with pethidine, morphine, midazolam for orthopedic surgeries 
in the lower limb. They selected 75 patients divided into three groups. 
Group BP (pethidine), group BM (morphine) & group BMM (morphine 
and midazolam). They concluded that BMM group produces most 
satisfactory analgesia with decreased incidence of nausea, vomiting. 
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MATERIALS AND METHODS 
This study was a randomized prospective single blinded study. 
This was conducted after getting approval of institutional ethical 
committee and written informed consent of parents or guardian. Patients 
who satisfied inclusion criteria are divided into two groups- Group BM 
and Group B. 
INCLUSION CRITERIA: 
 Age: 2 to 8 years 
 ASA: 1&2 
 Surgery: Elective lower abdominal surgery 
 Duration: less than 90 min 
EXCLUSION CRITERIA: 
 Infection at the site of caudal block 
 Patients with suspected coagulopathies & History of liver disease 
 Uncontrolled systemic disorder 
 H/O developmental delay, neurological disease 
 Skeletal deformities 
 Known allergy to study drugs 
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MATERIALS USED: 
 22G,24G intravenous cannula 
 Guedels oropharyngeal airway 
 Laryngoscopes of various sizes 
 Pediatric stylet 
 Appropriate size endotracheal tubes/Laryngeal mask airway 
 Drugs-Propofol, Sevoflurane, Succinylcholine, Normal Saline, 
Inj.Atropine, Inj.Ephedrine and other emergency drugs 
 Monitors-ECG,NIBP,SPO2,temperature monitoring 
 23G i.m. needle 
 2cc,5cc and 10cc syringe 
 Bupivacaine 20ml vial 0.5% 
 Preservative free Midazolam 5mg per ml 1ml ampoule 
 
PRIMARY PARAMETERS noted include 
 FLACC Pain score 
 Ramsay sedation score 
 Duration of analgesia 
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SECONDARY PARAMETERS include 
 Heart rate 
 Systolic, Diastolic and mean blood pressure 
 SPO2& Respiratory rate  
 Any adverse effects 
CONDUCTION OF THE STUDY: 
  This study was done at the department of Anesthesia, Institute of 
child Health and hospital for children between August and September of 
2014.The aim of the study was to compare the effect of adding 
Midazolam to caudal Bupivacaine and caudal Bupivacaine alone for 
providing postoperative analgesia in children undergoing elective lower 
abdominal surgeries. 
Sixty children between the age group 2 to 8 years scheduled for 
elective lower abdominal and genitourinary surgeries were randomly 
divided into two groups for study. 
Group BM-received caudal epidural block with 1ml per kg of 
0.25% Bupivacaine and 50microgm/kg of Midazolam 
Group B received caudal epidural block with 1ml per kg of 0.25% 
Bupivacaine. 
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The age and weight of child was recorded. Preoperative fasting  
protocols were strictly adhered to.  
All the operations were carried out under general anesthesia and 
the child was connected to NIBP, ECG, pulse oximeter, temperature and 
precordial stethoscope monitoring.   Intravenous line was secured with 
22G or 24G IV cannula into the vein on the dorsum of hand after 
applying EMLA cream. 
Anesthesia was induced in the theatre with Propofol 3mg/kg mixed 
with preservative free Lignocaine 0.5mg/kg. and Ketamine 0.5mg/kg (co 
induction).Anesthesia was maintained with 50%N2O &50%02 and 
Sevoflurane 1 to 2% using Jackson Rees modification of Ayre’s T piece 
with the patient in spontaneous respiration. 
After induction of anesthesia child was turned to left lateral 
position with assistant holding the mask, Group B received caudal 
epidural block with 1ml/kg of 0.25% Bupivacaine, Group BM received 
caudal epidural block with 1ml/kg of 0.25% Bupivacaine and 
50microgram/kg of Midazolam using 23G needle. 
Intraoperatively balanced salt solution was administered at the rate 
of 15-20mlperkg per hr. Heart rate ,blood pressure, respiratory rate,Spo2 
were recorded  regularly at an interval of 5minutes.Caudal block failure 
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was considered if rise in heart rate or MAP more than 20% of preincision 
values, inj.fentanyl 1mcg/kg iv was kept ready to be given to patients 
with block failure  for pain relief. 
The child was observed in the recovery room for 2 hours and then 
shifted to ward. 
Pain was assessed by using FLACC pain score, if pain score is 4 or 
above syp.paracetamol 15mg/kg is given. 
Post op sedation was assessed using Ramsay sedation score as follows: 
1. Anxious, agitated or both 
2. Co operative oriented, tranquil 
3. Response to commands only 
4. Brisk response to loud auditory stimulus 
5. Sluggish response to loud auditory stimulus 
6. No response to loud auditory stimulus 
The heart rate, NIBP and complications like vomiting, urinary retention 
and respiratory depression etc are recorded. Bradycardia was considered 
if heart rate less than 60/min and treated with Inj.Atropine, hypotension 
was considered if SBP(systolic blood pressure) was below 70+/2 age in 
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years with altered tissue perfusion and treated with fluid bolus .The 
respiratory depression was considered if SpO2 < 95%. 
Oral liquid feeds were allowed after 2 hours. All these children prior to 
discharge were examined for clinical evaluation of neurological system. 
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OBSERVATION AND RESULTS 
STASTICAL ANALYSIS: 
All statistical analysis was carried out using SPSS for windows 
version 20.0. The results are expressed as mean and standard deviation. 
Statistical analysis was carried out by student’s t-test for parametric data 
like age, weight, heart rate, blood pressure. Then parametric data like 
type of surgery, post operative complications were analyzed using chi 
square test and fisher’s exact test. A p value of <0.05 was considered as 
statistically significant. 
Both the groups were comparable in terms of age ,sex ,weight, and 
duration of surgery. 
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Table 1: Demographic Profile: Age 
Group N Mean Std. Deviation P value 
Group B 30 3.817 1.6634 
0.321 
Group BM 30 3.367 1.8144 
 
 
 
 
 
Comparing the two groups in terms of age, there is no considerable 
statistical difference. 
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Table 2: Demographic Profile: Sex 
Sex 
Group B Group BM 
P value 
No % No % 
Male 28 93.3% 26 86.7% 
0.389 
Female 2 6.7% 4 13.3% 
 
 
Comparing the two groups in terms of sex ratio, there is no 
considerable statistical difference. 
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Table 3: Demographic Profile: Weight 
Group N Mean Std. Deviation P value 
Group B 30 13.97 2.798 
0.533 
Group BM 30 13.47 3.35 
 
 
 
Comparing the two groups in terms of distribution of weight, there 
is no considerable statistical difference. 
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Table 4: Comparison of Type of Surgery 
Surgery 
Group B Group BM 
P value 
No % No % 
Circumcision 17 56.7% 15 50.0% 
0.226 Herniotomy 12 40.0% 10 33.3% 
PV sac ligation 1 3.3% 5 16.7% 
 
 
 
Comparing the two groups in terms of type of surgery, there is no 
considerable statistical difference. 
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Table 5: Duration of Surgery 
Duration of 
Surgery 
Group B Group BM 
P value 
No In min No In min 
Circumcision 17 435 15 390 
0.266 Herniotomy 12 360 10 315 
PV sac ligation 1 25 5 150 
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Comparing the two groups in terms of type of duration of surgery 
(in min); there is no considerable statistical difference. 
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Table 6: Duration of Analgesia 
Group N Mean 
Std. 
P value 
Deviation 
Group B 30 306.7 30.466 
0.000 Group BM 30 749.6 71.809 
 
 
 
The mean duration of analgesia in group B was 306.7+/30.466 and 
in group BM was 749.6+/71.809.The duration of analgesia was 
statistically significant with a p value of 0.000. 
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Table 7: FLACC Score of the two Groups 
  
Group B Group BM 
P value 
Time N Mean Std Deviation Mean 
Std 
Deviation 
0 hour 30 30 0.00 0.00 0.00 0.00 - 
2nd hour 30 30 0.07 0.37 0.00 0.00 0.321 
4th hour 24 30 2.63 0.02 0.00 0.00 0.000 
6th hour 0 30 4.00 0.00 0.83 0.53 
0.000 
 
8th hour 0 30 - - 1.70 0.47 - 
10th hour 0 28 - - 2.18 0.39 - 
12th hour 0 30 - - 2.93 0.69 - 
14th hour 0 24 - - 3.63 0.50 - 
16th hour 0 9 - - 4.00 0.00 - 
 
 Effective analgesia as indicated by the FLACC score of less than 4 
was observed up to 8 hours with bupivacaine with midazolam 
group and up to 4 hours in bupivacaine with saline postoperatively. 
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 The FLACC Score was comparable between the two groups for the 
first two hours and it is statistically not significant with a p value of 
0.321 
 The FLACC score were lower for midazolam group compared to 
bupivacaine group and it is statistically significant with a p value of 
0.000 in the 4th and 6th hour. 
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Table 8: FLACC Score of Frequency Distribution 
FLACC 
score 
hours 
Zero One Two Three Four Total 
B BM B BM B BM B BM B BM B BM 
0 hour 30 30 - - - - - - - - 30 30 
2nd hour 29 30 - - 1 - - - - - 30 30 
4th hour - 30 4 - 9 - 11 - 6 - 30 30 
6th hour - 7 0 21 0 2 - - 24 - 24 30 
8th hour - - - 9 
 
21 - - - - 0 30 
10th hour - - - - - 23 - 5 - - 0 28 
12th hour - - - - - 8 - 16 - 6 0 30 
14th hour - - - - - - - 9 - 15 0 24 
16th hour - - - - - - - - - 9 0 9 
 
This table shows the frequency distribution  of  FLACC  score 
among the two groups  over  the period  of  16 hours  measured  every  
two  hours. 
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30 Patients had score of zero in group BM  in the 4th hour 
compared to zero patients in group B. 
24 patients had score of 4 in group B in the 6th hour compared to 
zero patients in group BM.  
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FLACC score of 4 is attained only at the 12th hour in group BM.  
9 patients had score < 4 in the 14th hour in group BM. 
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Table 9: The Ramsay Sedation Score of the Two Groups 
Hours N Group B Group BM P value 
30 min 30 30 3 5.149 0.000 
60 min 30 30 3.205 4.216 0.000 
90 min 30 30 2.846 3.205 0.07 
2nd hr 30 30 2.284 2.405 0.156 
3rd hr 20 30 1.96 2.153 0.243 
4th hr 8 30 2.035 2.209 0.09 
5th hr 3 30 1.907 1.476 0.373 
6th hr 1 30 1 1 0.256 
 
The sedation score as assessed by Ramsay sedation score was 
significantly higher in the bupivacaine midazolam in the first one hour 
with a p value of 0.000. After that there is no considerable statistical 
difference between the two groups. 
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Table 10: Comparison of Intra-operative Heart rate between the 
Two groups 
Minutes N Group B Group BM P value 
Baseline 30 111.449 115.389 0.262 
After Induction 30 106.542 108.903 0.969 
5 min 30 110.062 114.661 0.813 
10 min 30 102.186 106.768 0.325 
15 min 30 100.574 103.463 0.551 
20 min 30 99.511 103.365 0.657 
25 min 30 99.028 103.976 0.609 
30 min 30 96.539 100.878 0.148 
35 min 30 97.464 99.359 0.771 
 
There was no considerable statistical difference between the two 
groups. 
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There was no considerable statistical difference between the two 
groups. 
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Table 11: Comparison of Post-operative Heart rate between the  
Two groups 
Minutes N Group B Group BM P value 
0 hour 30 98.844 102.332 0.321 
2nd hour 30 98.369 102.247 0.267 
4th hour 30 98.773 102.583 0.25 
8th hour 30 111.14 105.883 0.089 
12th hour 30 111.393 107.081 0.235 
16th hour 30 108.763 112.137 0.241 
20th hour 30 110.495 114.329 0.260 
24th hour 30 108.092 112.467 0.061 
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There was no considerable statistical difference between the two 
groups. 
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Table 12: Intra operative Systolic Blood pressure of the 
Two groups 
 
Group B Group BM P value 
Baseline 102.132 98.629 0.213 
After Induction 93.417 91.248 0.099 
5 min 96.405 93.608 0.058 
10 min 94.705 93.112 0.096 
15 min 95.115 91.997 0.341 
20 min 96.048 90.443 0.136 
25 min 97.64 92.105 0.208 
30 min 97.165 92.318 0.148 
35 min 91.493 - - 
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Intra operatively there was no considerable statistical difference 
between the two groups in terms of systolic blood pressure 
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Table 13: Post operative Systolic Blood pressure 
 
Group B Group BM P value 
0 hour 96.35 91.93 0.137 
2nd hour 95.30 91.25 0.174 
4th hour 96.00 91.05 0.595 
8th hour 102.34 97.41 0.586 
12th hour 97.57 93.66 0.182 
16th hour 96.43 92.35 0.191 
20th hour 96.29 94.23 0.772 
24th hour 96.83 93.42 0.358 
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In the postoperative period there was no considerable statistical 
difference between the two groups in terms of systolic blood pressure. 
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Table 14: Comparison of Mean of Diastolic Blood pressure 
Between the two groups – Intra-operative period 
Minutes N Group B Group BM P value 
Baseline 30 59.888 59.954 0.552 
After  
Induction 
30 56.145 54.757 0.053 
5 min 30 57.428 59.544 0.57 
10 min 30 57.986 58.645 0.784 
15 min 30 57.03 57.286 0.461 
20 min 30 57.317 57.265 0.366 
25 min 30 57.828 58.597 0.144 
30 min 30 57.773 - 0.148 
35 min 30 64.404 - 0.771 
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There was no considerable statistical difference between the two 
groups in terms of diastolic blood pressure. 
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Table 15: Comparison of Mean of Diastolic Blood pressure 
Between the two groups – Post-operative period 
N Group B Group BM P value 
0 hour 30 56.496 57.896 0.191 
2nd hour 30 59.149 57.536 0.558 
4th hour 30 58.576 58.238 0.593 
8th hour 30 60.687 58.372 0.67 
12th hour 30 57.651 59.155 0.513 
16th hour 30 58.204 59.487 0.795 
20th hour 30 58.845 59.567 0.147 
24th hour 30 60.277 60.4 0.918 
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In the postoperative diastolic blood pressure there was no 
considerable statistical difference between the two groups. 
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Table 16: Mean Arterial Pressure Intra operative period in both The 
groups 
N Group B Group BM P value 
Baseline 30 73.324 72.583 0.362 
After  
Induction 30 67.747 66.721 0.514 
5 min 30 69.579 70.536 0.732 
10 min 30 69.613 69.927 0.626 
15 min 30 69.334 68.58 0.9 
20 min 30 69.646 68.046 0.973 
25 min 30 70.285 69.237 0.586 
30 min 9 69.878 - - 
35 min 3 72.928 - - 
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There was no considerable statistical difference between the groups 
in terms of mean arterial pressure in intraop period. 
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Table 17: Mean Arterial Pressure Post-operative period in both  
The groups 
N Group B Group BM P value 
0 hour 30 69.306 68.813 0.774 
2nd hour 30 70.624 68.542 0.355 
4th hour 30 69.73 68.823 0.518 
8th hour 30 73.261 69.097 0.088 
12th hour 30 69.866 69.478 0.731 
16th hour 30 70.401 70.08 0.8 
20th hour 30 70.999 70.712 0.35 
24th hour 30 71.947 71.071 0.674 
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There was no considerable statistical difference between the two 
groups in the postoperative mean arterial blood pressure. 
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COMPLICATIONS: 
 Respiratory depression in both the groups 
 
N Group B Group BM P value 
Respiratory 
Depression 
(Absent) 
30 50.0% 50.0% - 
 
 
There was no Respiratory depression in BM(bupivacaine 
midazolam) group similar to B(bupivacaine) group. 
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 Urinary retention in both the groups 
  N Group B Group BM P value 
Urinary retention 
(Absent) 30 50.0% 50.0% - 
 
 
 
There was no incidence of Urinary retention in both the groups. 
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 PONV in both the groups 
PONV N Group B Group BM P value 
Present 1 1 0 0.313 
Absent 29 49.2% 50.8% - 
 
 
 
PONV occurred in only one patient in the control group which is 
not statistically significant between the two groups. 
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DISCUSSION 
Caudal epidural anesthesia is an effective means of providing pain 
relief in children. Apart from producing adequate intra operative and 
postoperative analgesia it has various beneficial effects. It reduces the 
stress hormone levels produced during anesthesia. It reduces the 
intraoperative and postoperative analgesic requirements in the form of 
narcotics and NSAIDS. It provides faster and comfortable wake up times, 
helps in early ambulation and less hospital stay, thereby alleviating most 
of the anxiety and burden of the child’s parents. 
Though it produced excellent analgesia the main disadvantage of 
this technique is short duration of action. Even the long acting local 
anesthetics like Bupivacaine   provides only 4 to 8 hours of analgesia, so 
patients required additional analgesic requirements in the postoperative 
period. This resulted in excessive use of opioids postoperatively which 
resulted in significant respiratory depression and PONV(Post operative 
Nausea and vomiting).Though continuous caudal catheter technique can 
be used to provide postoperative analgesia, it has a disadvantage of 
producing severe catheter related infection so it is not popularly used. 
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This resulted in the usage of various adjuvants to the local 
anesthetics to prolong their analgesic effect, like adrenaline, ketamine, 
clonidine, dexmedetomidine, neostigmine etc., 
One such adjuvant used was midazolam, a GABA agonist. This 
drug has prolonged duration of analgesia without producing significant 
side effects. 
FLACC SCORE: 
The two groups Bupivacaine with saline group(group B) and 
Bupivacaine with Midazolam were compared with respect to FLACC 
scores achieved at various interval of time (0 hr and every 2hours till 16th 
hour and 20th&24thhour).The FLACC score of less than 4 was assumed as 
effective analgesia. 
The effective analgesia was observed up to 8hours with 
Bupivacaine and Midazolam group compared to 4 hours with bupivacaine 
and saline group. 
The duration of postoperative analgesia in Bupivacaine and 
Midazolam  group was prolonged. The mean duration of postoperative 
analgesia in group BM was 12.49+/1.19 hours   and that of group B was 
5.11+/0.50 hours. This was statistically significant with a p < 0.05. 
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These findings were similar to the results of Mahajan which reports 
that addition of midazolam (50 mcg per kg) to bupivacaine provides 
longer duration of analgesia (i.e.11+/0.5hr) compared to bupivacaine 
group (7.4+/2.1hr). 
This also correlates with the results of Kumar and colleagues, Bano 
and colleagues, IDREAS and colleagues, Naugib et al and Himabandu 
and colleagues etc where duration of analgesia is prolonged in 
bupivacaine midazolam group. 
SEDATION SCORES: 
The sedation scores were higher in the first one hour of surgery 
with a significant difference (p value < 0.05).this correlates with the 
results of Bano et al. 
COMPLICATIONS: 
There was no complication in both the groups except for vomiting in one 
child in the control group which was not statistically significant. 
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SUMMARY 
This  study  was  conducted  to  compare   the  efficacy  of   
Midazolam  as an adjuvant to Bupivacaine  Vs  plain Bupivacaine for 
caudal analgesia in children undergoing lower abdominal surgeries. 
The following observations were made: 
-Duration of analgesia was higher in Bupivacaine with Midazolam 
(750 min) group compared to plain Bupivacaine(306 min) group, which 
was statistically significant. 
-FLACC scores for analgesic assessment were better in the 
Bupivacaine with Midazolam group   when compared to Bupivacaine 
group, which was statistically significant. 
-Sedation scores as assessed by Ramsay sedation score was higher 
in the Bupivacaine with Midazolam group compared to Bupivacaine for 
1st hour   postoperatively which was statistically significant. 
- In both the groups, hemodynamic changes in intra operative and 
post operative period were comparable and insignificant. 
 -In both the groups, no adverse effects occurred except for 
vomiting in one child in control group which was not statistically 
significant. 
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CONCLUSION 
From my study I conclude that administration of preservative free 
midazolam with bupivacaine for caudal epidural block increases the 
duration of post operative analgesia without producing any adverse 
effects compared with bupivacaine alone. Thus low dose preservative free 
midazolam can be used as additive to local anesthetics in caudal epidural 
anesthesia for prolonging analgesic effect. 
 
 
 
 
 
 
 
 
 
  
 
BIBLIOGRAPHY 
1.  S MALVIYA A Practice of regional anesthesia for infants and 
children 2002, 
2.  MATHER L MACKIE J The incidence of postoperative pain in 
children 1983-15: 271-282 
3.  ANAND K J, CARR D The neuroanatomy, Neurophsiology, 
Neurochemistry of pain stress, analgesia in newborn and children –
pediatric clinics of North America 1989-36:795 
4.  FITZERALD M The neurobiology of foetal and infant pain .The 
textbook of pain 4th edition, 199,235-252 
5.  Royal college of anesthetists-guidelines for the use of NSAIDS in 
the perioperative period 1998 
6.  TOBIAS JD- Weak analgesia and NSAIDS in the management of 
children with acute pain 
7.  HAROLD ELLIS Anatomy for anaesthesists-8th edition: 107-112 
8.  MILLERS Textbook of anaesthesia-7th edition 1628-1634, 
9.  COUSINS & BRIDENBAUGH’s neural blockade in clinical 
anesthesia &pain medicine 4th edition: 595-699 
  
 
10.  MOTOYAMA & DAVIS SMITH’S Anesthesia for infants and 
children 7th edition 
11.  GREGORY’S Pediatric Anesthesia 5th edition 
12.  REBECCA JACOB understanding pediatric anesthesia 2nd edition, 
96-110 
13.  G.EDWARD MORGAN, Clinical anesthesiology 4th edition, 314-
316 
14.  DALENS pediatric anesthesia principles and practice, 2002, 528-
575 
15.  STOELTING pharmacology and physiology in anesthetic practice, 
4th edition 179-202 
16.  EDWARD MORGAN clinical anesthesiology 4th edition, 314-316 
17.  GOODMAN & GILLMAN Textbook of pharmacology 
18.  NAUGIB M et al, Midazolam for caudal analgesia in children: 
comparison with caudal bupivacaine.Canadian journal of 
anaesthesia1995 Sep; 42(9):758-764 
19. Mahajan R, batra yk,Grover vk,kajal j , Comparative study of 
caudal bupivacaine and midazolam bupivacaine mixture for 
postoperative analgesia in children undergoing genitourinary 
  
 
surgery ,international journal of clinical pharmacology and 
therapeutics,2001,39(3):116-120 
20. Pradhan B et al Midazolam for caudal analgesia in children 
comparison with caudal bupivacaine, Kathmandu Univ med 
journal, 2008, 6(2):166-172 
21. S Gulec,B Buyukkidan et al Comparison of caudal bupvacaine, 
bupivacaine morphine and bupivacaine midazolam mixture for 
postoperative analgesia in children ,European journal of 
anesthesiology 1998 vol 15 ,issue 2,161-165. 
22. Kumar p, Rudra et al Caudal additives in paediatrics, a comparison 
among midazolam, ketamine and neostigmine co-administered 
with bupivacaine. Anaesthesia and Analgesia July 2005 vol.101 
issue 1, 69-73 
23. Idris ali et al Caudal bupivacaine –midazolam for postoperative 
analgesia in children, 2014 
24. Bano F,Haider S,Sultan st Comparison of caudal bupivacaine and 
bupivacaine midazolam for postoperative analgesia in children ; 
journal of college of physicians and surgeons 2004,14(2),65-68 
  
 
25. J.Y.Hong ,I.h.lee,S,K.Shin et al Caudal midazolam doesnot affect 
sevoflurane requirement and recovery in paediatric day case 
hernioplasty .2008,vol 52,issue 10,1411-1414 
26. Shahriari et al, Comparison of midazolam with lidocaine & 
fentanyl for caudal analgesia in children 2007 j.med sci 7(4) 660-
664 
27. M Abosedira et al  Does midazolam improve caudal Ropivacaine 
analgesia in cadults 2009 vol 23 n 2 
28.  Tomoki Nishiyama et al Midazolam improves postoperative 
epidural analgesia with continuous infusion of local anesthetics, 
Canadian journal of anesthesia 1998, vol 45, and issue 6,551-555 
29.  Mark ansermino Non opioid additives to local anaesthetics for 
caudal blockade in children 2003 vol 13, issue 7,561-573 
30. Yaksh, Tong et al The use of intrathecal midazolam in humans. 
Anesthesia and analgesia 2000 vole 98 issue 6 1536-1545 
31. SN Khalil et al Presurgical caudal block attenuates stress response 
in children University of Texas, journal of anaesthesiology, 2005, 
18(2), 391-400. 
  
 
32. Steven et al  Anticholinergics and ketamine sedation in children 
academic emergency and medicine vol 17,issue 2,pg 157-162 feb 
2010 
33. Lance brown et al Adjunctive atropine is unnecessary during 
ketamine sedation in children Academic emergency medicine vol 
15,issue 4 ,314-318.aor 2008 
34. Rapeport et al The use of ketofol in conjunction with regional 
anaesthesia anaesthesia and intensive care jan 2009 
35. Sanjay et al Combining ketamine and propofol for emergency 
departmental procedural sedation 
36. Akin et al Propofol and Propofol –ketamine in paediatric patients 
undergoing cardiac catherization 
 
  
  
  
 
INFORMATION TO PARTICIPENTS 
Investigator                     : Dr.REVATHI.T. 
Name of the Participant: 
Title  :        
 A Prospective,   randomized control study   comparing 
caudal block using bupivacaine  with, bupivacaine and midazolam  
for postoperative analgesia, in children undergoing elective lower 
abdominal surgeries. 
You are invited to take part in this research study. We have got 
approval from the IEC. Your are asked to participate because you satisfy 
the eligibility criteria .We want to compare and study the safety and 
efficacy of caudal block using bupivacaine with, bupivacaine and 
midazolam 
What is the Purpose of the Research: 
For lower abdominal  surgeries,  patient is anaesthesised, caudal 
block with either bupivacaine   or bupivacaine and midazolam, is given . 
In this study is done to compare  the efficacy and safety of using caudal 
epidural administration of preservative free midazolam with   bupivacaine 
vs bupivacaine for providing post op pain relief in children undergoing 
lower abdominal surgeries 
  
 
 The Study Design: 
All the patients in the study will be divided into two groups. 
Group1- caudal block with  1ml/kg of0.25% bupivacaine 
Group 2- caudal block with 1ml/kg of0.25% bupivacaine and 
50μg/kg of midazolam 
All children will be  given general anaesthesia  
Benefits                      
 Prolonged  post operative pain relief-thereby reducing 
postoperative analgesic requirement in the first 24h (including NSAIDS n 
opiods) 
Discomforts and risks 
Hypersensitivity to local anaesthetics 
 Respiratory depression -very rare at this dose of midazolam and 
if it all it occurs it is easily recognisable n treatable 
 Hypotension and bradycardia  
 Complications related to caudal block technique 
This intervention has been shown to be well tolerated as shown by 
previous studies. And if you do not want to participate you will have 
  
 
alternative of setting the standard treatment and your safety is our prime 
concern. 
Time : 
Date : 
Place : 
 
Signature / Thumb Impression of Patient: 
 
Patient Name: 
 
Signature of the Investigator : ____________________________ 
Name of the Investigator  : ____________________________ 
 
 
 
 
  
  
 
PATIENT CONSENT FORM 
 
Study title        :          “A Prospective,   randomized control  study   
comparing caudal  block using bupivacaine   with  bupivacaine and 
midazolam for postoperative analgesia  in children undergoing elective  
lower abdominal  surgeries.  
                                        
Study center:  INSTITUTE  OF CHILD HEALTH 
EGMORE 
CHENNAI - 8 
                                 
       
Participant name :                                                Age:                         Sex:                          
I.P.No: 
I confirm that I have understood the purpose of procedure for the 
above study . I have the opportunity to ask the question and all my 
questions and doubts have been answered to my satisfaction. 
I have been explained about the pitfall in the procedure.  I have 
been explained about the safety,advantage and disadvantage of the 
technique. 
  
 
I understand that my participation in the study is voluntary and that 
I am free to withdraw at anytime without giving any reason. 
I understand that investigator ,regulatory authorities and the ethics 
committee will not need my permission to look at my health records both 
in respect to current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study . I understand that my 
identity will not be revealed in any information released to third parties or 
published , unless as required under the law . I agree not to restrict the use 
of any data or results that arise from the study . 
Time : 
Date : 
Place : 
Signature / Thumb Impression of Patient: 
 
Patient Name: 
 
Signature of the Investigator : ____________________________ 
Name of the Investigator  : ____________________________ 
 
  
 
PROFORMA 
Date:    Roll No.   Group 
Name :   Age/Sex:   IP No: 
Wt: 
Diagnosis: 
Surgical Procedure Done: 
Pre OP Assessment: 
History: 
Any H/O Co-morbid illness 
Any H/O previous surgery 
O/E:     CYS:    RS: 
BP :     PR:    SPO2: 
ASA Status: 
Drugs Used: 
Induction :       Maintenance: 
Time of administration of Caudal Block: 
Duration of Surgery: 
Intra OP events 
Time Events HR HP SPO2 
     
     
     
     
 
  
 
Post OP events 
Time (Hrs HR BP Pain Score Sedation 
Score 
     
     
     
     
 
Complications : 
Grroup Respiratory 
Depression 
Apnea Urinary 
Retention 
Nausea & 
Vomiting 
     
     
     
     
 
     DOSE  TIME 
Inj – ATROPINE 
Inj - EPHEDRINE 
 
 
  
 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
